Reaction

Exposure During Breast Feeding reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,317 reports · 44 co-occurring drugs

As of the last recalculation, Exposure During Breast Feeding appears in 3,317 FAERS reports alongside 44 co-occurring drug terms. The strongest observed disproportionality signal is NEVIRAPINE (PRR 90.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Nevirapine	125	90.3	91.6
Copper	354	57.6	58.0
Nicotine Polacrilex Mini	114	49.3	49.7
Nicotine Polarilex	114	49.3	49.7
Zidovudine	97	46.9	47.2
Buprenorphine Hydrochloride, Naloxone Hydrochloride	125	33.7	33.9
Lamivudine Oral	104	26.6	26.7
Lamivudine	105	22.0	22.1
Nicotine Polacrilex	115	19.5	19.6
Nicotine	118	18.9	19.0
Insulin Human	60	9.6	9.6
Ampicillin	12	9.1	9.1
Ampicillin Sodium	12	9.1	9.1
Fluoxetine Hydrochloride	144	7.4	7.4
Efavirenz	12	6.8	6.8
Lamotirigine	64	5.7	5.7
Lamotrigine Extended-Release	64	5.7	5.7
Lamotrigine Chewable Dispersible	64	5.7	5.7
Lamotrigine	114	5.6	5.6
Olanzapine Pamoate	34	5.3	5.3
Abacavir Sulfate	8	5.2	5.2
Levonorgestrel	150	4.8	4.9
Labetalol	10	4.7	4.7
Aripiprazole Oral	27	4.1	4.1
Aripiprazole Orally Disintegrating	27	4.1	4.1
Methadone Hydrochloride	7	4.1	4.1
Dorzolamide Hydrochloride And Timolol Maleate	5	4.0	4.0
Misoprostol	6	3.9	3.9
Eculizumab	32	3.7	3.7
Insulin Glulisine	6	3.7	3.7
Tenofovir Disoproxil Fumarate Tablets	5	3.6	3.6
Insulin Lispro	77	3.6	3.6
Methadone	24	3.5	3.5
Levetiracetam	74	3.5	3.5
Agalsidase Beta	5	3.4	3.4
Sodium Oxybate	35	3.4	3.4
Levetiracetam In Sodium Chloride	38	3.1	3.1
Levetiracetam Oral	38	3.1	3.1
Levetiracetam Injection	38	3.1	3.1
Adalimumab	312	3.0	3.0
Atomoxetine Hydrochloride	11	2.9	2.9
Buprenorphine	39	2.7	2.7
Glatiramer Acetate	23	2.4	2.4
Etonogestrel	16	2.1	2.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.